Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

45%

5 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

Phase 3
3(42.9%)
Phase 4
2(28.6%)
Phase 1
2(28.6%)
7Total
Phase 3(3)
Phase 4(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials
NCT06525389Phase 3Not Yet Recruiting

Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)

Role: collaborator

NCT07486024Phase 3Not Yet Recruiting

Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)

Role: collaborator

NCT06349759Phase 3Completed

Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances

Role: collaborator

NCT07231796Recruiting

Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience

Role: collaborator

NCT06135324Active Not Recruiting

Impairments That Affect Correct Inhaler Use in COPD

Role: collaborator

NCT06875258Phase 4Recruiting

PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)

Role: collaborator

NCT01848028Recruiting

PsoBest - The German Psoriasis Registry

Role: collaborator

NCT05165485Phase 4Completed

Phase 4 COPD and Suboptimal Inspiratory Flow Rate

Role: collaborator

NCT06471088Recruiting

Safety and Efficacy Evaluation of <Dovprela Tablets 200 mg> by Post-marketing Surveillance

Role: lead

NCT06273254Phase 1Not Yet Recruiting

A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

Role: lead

NCT06266988Phase 1Not Yet Recruiting

A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

Role: lead

All 11 trials loaded